![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, September 16, 2018 4:37:12 PM
Yes. Additional information is always part of the process.
Paul Knopick
---------- Forwarded message ---------
From: Vapor09 <>
Date: Fri, Sep 14, 2018 at 3:57 PM
Subject: Information Request
To: <info@bielcorp.com>
Hello,
I am a shareholder and would like to know if the FDA has requested any additional information on the Actipatch 510(k) submitted in July.
A simple yes or no will suffice.
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM